Back to all stories
The courtroom of U.S. District Judge Hon. Brett H. Ludwig in the Federal Building during Doors Open Milwaukee 2023 in Milwaukee, Wisconsin (United States).
Photo: Michael Barera | CC BY-SA 4.0 | Wikimedia Commons

Purdue Pharma Criminal Sentence Triggers Final Phase Of Opioid Settlement

Purdue Pharma is set to be sentenced in a criminal case, a step that clears the way for its multibillion-dollar opioid settlement to move forward. A federal judge is expected to order Purdue to forfeit $225 million to the Justice Department on Tuesday under the 2020 plea deal. If the judge signs off, the government will not collect $5.3 billion in additional criminal forfeitures and fines or $2.8 billion in civil liabilities, and those sums would fold into the broader settlement.

Another judge has already approved the wider settlement, which could take effect on May 1 and requires Sackler family members to pay up to $7 billion over 15 years. Purdue pleaded guilty in 2020 to three federal criminal charges for failing to prevent drug diversion and for paying doctors and a medical records company to boost opioid prescribing. The company has already spent more than $1 billion on professional fees related to its bankruptcy reorganization, highlighting the case's complexity and cost.

Coverage has shifted from early focus on a contested bankruptcy and legal protections for the Sacklers to newer reporting that a criminal sentence could unlock settlement funds for victims. Recent reporting, led by outlets such as PBS, added concrete details about the judge's expected $225 million forfeiture order and how billions more would be folded into the approved settlement.

Opioid Litigation and Public Health Corporate Accountability and White-Collar Crime Opioid Crisis Corporate Accountability and Courts
This story is compiled from 2 sources using AI-assisted curation and analysis. Original reporting is attributed below. Learn about our methodology.

📌 Key Facts

  • A recent criminal sentence for OxyContin maker Purdue Pharma clears the way for finalizing its multibillion-dollar opioid settlement.
  • A judge is expected to order Purdue to forfeit $225 million to the Justice Department on Tuesday under the company’s 2020 plea deal.
  • If the judge signs off, the government will forgo collecting $5.3 billion in additional criminal forfeitures/fines and $2.8 billion in civil liabilities, folding those amounts into the broader settlement structure.
  • The broader settlement, already approved by another judge, could take effect May 1 and would require Sackler family members to pay up to $7 billion over 15 years.
  • Purdue pleaded guilty in 2020 to three federal criminal charges, including failures to prevent diversion and paying doctors and an electronic medical records company to drive opioid prescribing.
  • As of late last year, Purdue had spent over $1 billion on professional fees related to the bankruptcy reorganization, underscoring the case’s complexity and cost.

📰 Source Timeline (2)

Follow how coverage of this story developed over time

April 21, 2026
3:06 PM
A criminal sentence for OxyContin maker Purdue Pharma clears the way for finalizing its settlement
PBS News by Geoff Mulvihill, Associated Press
New information:
  • Confirms the judge is expected to order Purdue to forfeit $225 million to the Justice Department on Tuesday under the 2020 plea deal.
  • Details that, if the judge signs off, the government will not collect $5.3 billion in additional criminal forfeitures/fines and $2.8 billion in civil liabilities, folding those amounts into the broader settlement structure.
  • Clarifies that the broader settlement, already approved by another judge, could take effect May 1 and will require Sackler family members to pay up to $7 billion over 15 years.
  • Reiterates and contextualizes Purdue’s 2020 guilty plea to three federal criminal charges, including failures to prevent diversion and paying doctors and an electronic medical records company to drive opioid prescribing.
  • Notes that Purdue has already spent over $1 billion on professional fees related to the reorganization as of late last year, underscoring the complexity and cost of the case.